People | August 21, 2024
Wanbury appoints Pradeep Patni as CEO of India Formulation Business
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The emergence of new infections in India is a growing concern
The robotic surgery program has continually pushed the boundaries of medical technology
Becomes the first rehab & recovery center in east India to earn NABH accreditation
The partnership marks a significant milestone in integrating digital health education into medical curricula
European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
For the 2024 outlook, sales growth is now expected to be 22-28% at CER
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
Subscribe To Our Newsletter & Stay Updated
